Horizon Pharma (NASDAQ:HZNP) will post its quarterly earnings results before the market opens on Monday, February 5th. Analysts expect Horizon Pharma to post earnings of $0.23 per share for the quarter.
Horizon Pharma (NASDAQ:HZNP) last announced its earnings results on Monday, November 6th. The biopharmaceutical company reported $0.26 earnings per share for the quarter, beating analysts’ consensus estimates of $0.22 by $0.04. The business had revenue of $271.60 million for the quarter, compared to the consensus estimate of $259.74 million. Horizon Pharma had a negative net margin of 45.28% and a positive return on equity of 20.22%. Horizon Pharma’s quarterly revenue was up 30.1% on a year-over-year basis. During the same period last year, the firm posted $0.70 earnings per share. On average, analysts expect Horizon Pharma to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Shares of Horizon Pharma (NASDAQ HZNP) opened at $15.60 on Monday. The firm has a market cap of $2,560.00, a P/E ratio of -5.13, a P/E/G ratio of 0.73 and a beta of 1.30. The company has a debt-to-equity ratio of 1.89, a current ratio of 1.64 and a quick ratio of 1.52. Horizon Pharma has a one year low of $9.45 and a one year high of $17.69.
Horizon Pharma Company Profile
Horizon Pharma Public Limited Company is a biopharmaceutical company. The Company is focused on identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. As of December 31, 2016, the Company marketed 11 medicines through its orphan, rheumatology and primary care business units.
Receive News & Ratings for Horizon Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Horizon Pharma and related companies with MarketBeat.com's FREE daily email newsletter.